Inside Washington: Major Changes Ahead for FDA

by Jill Wechsler A new FDA commissioner will have to oversee agency consolidation and new initiatives to counter bioterrorism.

Related Content:

Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?

Bioinformatics Databases ? Questions of Copyright

European Editor's Report ? An Industry Comes of Age